Clinical Characteristics, Predictors and Outcome of Children with Complicated Parapneumonic Effusion: A Single Centre Experience
Parapneumonic Effusion in Children
Vol. 16 No. 1 : 2021 (123-133)
Abstract
Parapneumonic effusions (PPE) is a complication of bacterial pneumonia. Factors that contribute to complicated PPE remain uncertain. This study was aimed to describe the characteristics, clinical predictors and outcome of children with parapneumonic effusion (PPE) in Universiti Kebangsaan Malaysia Medical Centre (UKMMC). A retrospective study on children with PPE who were admitted to UKMMC between January 2010 to December 2017 was conducted. Patients were categorised into 2 groups: simple and complicated PPE. Of 45 patients recruited, 20 (44.4%) patients had simple PPE and 25 (55.6%) had complicated PPE. Their median age was 32 months (IQR 16-63). The most common isolated organism was Streptococcus pneumoniae (61.9%), followed by Mycoplasma pneumoniae (19.0%) and Staphylococcus aureus (4.8%). Only 11.1% of patients received pneumococcal vaccination. There was no statistical significant difference in clinical features between simple and complicated PPE. Only 62.2% patients had ultrasound thorax done. Majority (95.0%) of patients with simple PPE were successfully treated with intravenous antibiotics alone. Sixty percent of patients with complicated PPE needed surgical intervention. Mean length of hospital stay for simple PPE was 10 (4.0) days and complicated PPE was 28 (16.5) days. In conclusion, clinical features could not predict complicated PPE. Use of ultrasound thorax as the main investigation tool for diagnosis and staging should be emphasised. Antibiotics therapy alone is effective therapy for simple PPE, while in complicated PPE, larger prospective studies are required to investigate which children benefit significantly from more intensive intervention.
Keywords :
children,
clinical characteristics,
parapneumonic effusion,
Correspondance Address
Associate Professor Dr Hasniah Abdul Latif. Department of Paediatrics, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia. Tel: +603 91455395/91457888 Email: hasniah@ppukm.ukm.edu.my
References
Abu Zarrin, A.M., Nor Munirah, M.A., Mohammad Izwan, E.O., Abdullah, A.S., Hanani, A.Y. 2020. Antibiotic susceptibility of Staphylococcus epidermidis among Undergraduate Students in Malaysia Public University Health Campus. Med & Health 15(1): 166-76
Balfour-Lynn, I.M., Abrahamson, E., Cohen, G., Hartley, J., King, S., Parikh, D., Spencer, D., Thomson, A.H., Urquhart, D., Paediatric Pleural Diseases Subcommittee of the BTS Standards of Care Committee. 2005. BTS guidelines for the management of pleural infection in children. Thorax 60(Suppl 1): i1-21.
Byington, C.L., Spencer, L.Y., Johnson, T.A., Pavia, A.T., Allen, D., Mason, E.O., Kaplan, S., Carroll, K.C., Daly, J.A., Christenson, J.C., Samore, M.H. 2002. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 34(4): 434-40.
Elemraid, M.A., Thomas, M.F., Blain, A.P., Rushton, S.P., Spencer, D.A., Gennery, A.R., Clark, J.E., North East of England Pediatric Respiratory Infection Study Group Newcastle upon Tyne, UK. 2015. Risk factors for the development of pleural empyema in children. Pediatr Pulmonol 50(7): 721-6.
François, P., Desrumaux, A., Cans, C., Pin, I., Pavese, P., Labarère, J. 2010. Prevalence and risk factors of suppurative complications in children with pneumonia. Acta Paediatr 99(6): 861-6.
Gayretli-Aydın, Z.G., Tanır, G., Bayhan, G., Aydın-Teke, T., Öz, F.N., Metin-Akcan, Ö., Kaman, A. 2016. Evaluation of complicated and uncomplicated parapneumonic effusion in children. Turk J Pediatr 58(6): 623-31.
Grijalva, C.G., Nuorti, J.P., Zhu, Y., Griffin, M.R. 2010. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis 50(6): 805-13.
Hafen, G.M., Grenzbach, A.C., Moeller, A., Rochat, M.K. 2016. Lack of concordance in parapneumonic effusion management in children in central Europe. Pediatr Pulmonol 51(4): 411-7.
Hamm, H., Light, R.W. 1997. Parapneumonic effusion and empyema. Eur Respir J 10(5): 1150-6.
Islam, S., Calkins, C.M., Goldin, A.B., Chen, C., Downard, C.D., Huang, E.Y., Cassidy, L., Saito, J., Blakely, M.L., Rangel, S.J., Arca, M.J., Abdullah, F., St Peter, S.D., APSA Outcomes and Clinical Trials Committee, 2011-2012. 2012. The diagnosis and management of empyema in children: a comprehensive review from the APSA Outcomes and Clinical Trials Committee. J Pediatr Surg 47(11): 2101-10.
Jaffé, A., Balfour-Lynn, I.M. 2005. Management of empyema in children. Pediatr Pulmonol 40(2): 148-56.
Kaplan, S.L., Mason, E.O., Jr., Wald, E.R., Schutze, G.E., Bradley, J.S., Tan, T.Q., Hoffman, J.A., Givner, L.B., Yogev, R., Barson, W.J. 2004. Decrease of invasive pneumococcal infections in children among 8 children’s hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113(3 Pt 1): 443-9.
Krenke, K., Urbankowska, E., Urbankowski, T., Lange, J., Kulus, M. 2016. Clinical characteristics of 323 children with parapneumonic pleural effusion and pleural empyema due to community acquired pneumonia. J Infect Chemother 22(5): 292-7.
Kurian, J., Levin, T.L., Han, B.K., Taragin, B.H., Weinstein, S. 2009. Comparison of ultrasound and CT in the evaluation of pneumonia complicated by parapneumonic effusion in children. AJR Am J Roentgenol 193(6): 1648-54.
Li, S.T., Tancredi, D.J. 2010. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics 125(1): 26-33.
Liese, J.G., Schoen, C., Van Der Linden, M., Lehmann, L., Goettler, D., Keller, S., Maier, A., Segerer, F., Rose, M.A., Streng, A. 2019. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance study. Clin Microbiol Infect 25(7): 857-64.
Lin, C.J., Chen, P.Y., Huang, F.L., Lee, T., Chi, C.S., Lin, C.Y. 2006. Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children. J Microbiol Immunol Infect 39(6): 489-95.
Nyambat, B., Kilgore, P.E., Yong, D.E., Anh, D.D., Chiu, C.H., Shen, X., Jodar, L., Ng, T.L., Bock, H.L., Hausdorff, W.P. 2008. Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease. BMC Infect Dis 8: 90.
Obando, I., Muñoz-Almagro, C., Arroyo, L.A., Tarrago, D., Sanchez-Tatay, D., Moreno-Perez, D., Dhillon, S.S., Esteva, C., Hernandez-Bou, S., Garcia-Garcia, J.J., Hausdorff, W.P., Brueggemann, A.B. 2008. Pediatric parapneumonic empyema, Spain. Emerging Infect Dis 14(9): 1390-7.
Proesmans, M., Gijsens, B., Van De Wijdeven, P., De Caluwe, H., Verhaegen, J., Lagrou, K., Van Even, E., Vermeulen, F., De Boeck, K. 2014. Clinical outcome of parapneumonic empyema in children treated according to a standardized medical treatment. Eur J Pediatr 173(10): 1339-45.
Roxburgh, C.S., Youngson, G.G., Townend, J.A., Turner, S.W. 2008. Trends in pneumonia and empyema in Scottish children in the past 25 years. Arch Dis Child 93(4): 316-8.
Sakran, W., Ababseh Zel, D., Miron, D., Koren, A. 2014. Thoracic empyema in children: clinical presentation, microbiology analysis and therapeutic options. J Infect Chemother 20(4): 262-5.
Segerer, F.J., Seeger, K., Maier, A., Hagemann, C., Schoen, C., Van Der Linden, M., Streng, A., Rose, M.A., Liese, J.G. 2017. Therapy of 645 children with parapneumonic effusion and empyema-A German nationwide surveillance study. Pediatr Pulmonol 52(4): 540-7.
Shah, S.S., Ten Have, T.R., Metlay, J.P. 2010. Costs of treating children with complicated pneumonia: a comparison of primary video-assisted thoracoscopic surgery and chest tube placement. Pediatr Pulmonol 45(1): 71-7.
Sonnappa, S., Cohen, G., Owens, C.M., Van Doorn, C., Cairns, J., Stanojevic, S., Elliott, M.J., Jaffé, A. 2006. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 174(2): 221-7.
World Health Organization. 2010. ICD10 - International Statistical Classification of Diseases and Related Health Problems. https://icd.who.int/browse10/2010/en#/J85-J86 [14 October 2020].
Yu, D., Buchvald, F., Brandt, B., Nielsen, K.G. 2014. Seventeen-year study shows rise in parapneumonic effusion and empyema with higher treatment failure after chest tube drainage. Acta Paediatr 103(1): 93-9.
